Last reviewed · How we verify
Fentanyl 100 mcg
At a glance
| Generic name | Fentanyl 100 mcg |
|---|---|
| Also known as | High Dose |
| Sponsor | Ohio State University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy (PHASE3)
- Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery (NA)
- Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery (NA)
- Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine (PHASE4)
- Lidocaine-based Versus Opioid-based Induction of Anesthesia in Emergency Laparotomy (PHASE4)
- Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration (PHASE3)
- Transition From Acute to Chronic Opioid Use and Chronic Pain (EARLY_PHASE1)
- Paravertebral Calcitonin in Thoracotomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fentanyl 100 mcg CI brief — competitive landscape report
- Fentanyl 100 mcg updates RSS · CI watch RSS
- Ohio State University portfolio CI